Page last updated: 2024-09-04

butylscopolammonium bromide and Laryngeal Neoplasms

butylscopolammonium bromide has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuara, ML; Barcia, E; Negro, S; Reyes, R; Sánchez, Y1

Other Studies

1 other study(ies) available for butylscopolammonium bromide and Laryngeal Neoplasms

ArticleYear
Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
    International journal of pharmaceutics, 2006, Jan-13, Volume: 307, Issue:2

    Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Antiemetics; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Drug Combinations; Drug Stability; Drug Storage; Female; Haloperidol; Humans; Injections, Subcutaneous; Laryngeal Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Morphine; Muscarinic Antagonists; Palliative Care; Retrospective Studies; Time Factors

2006